Evogliptin Impurity R5

Beneficial Effects of Evogliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, on Adiposity with Increased Ppargc1a in White Adipose Tissue in Obese Mice
Yu-Na Chae, Tae-Hyoung Kim, Mi-Kyung Kim, Chang-Yell Shin, Il-Hoon Jung, Yong Sung Sohn, and Moon-Ho Son
PLoS One. 2015; 10(12): e0144064.

Evogliptin Impurity R5 is chemically (R)-4-((R)-3-Amino-4-(2,5-difluorophenyl)butanoyl)-3-(tert-butoxymethyl)piperazin-2-one (2R,3R)-2,3-dihydroxysuccinate. Evogliptin Impurity R5 is supplied with detailed characterization data compliant with regulatory guideline. Evogliptin Impurity R5 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Evogliptin Tartarate.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.